Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

The immune response has been recognized as a major tumor-eradication component of radiotherapy. This review studies, under a clinical perspective, two contrasting effects of radiotherapy, namely immunosuppression and radiovaccination. We critically reviewed the available clinical and experimental experience on radiotherapy-induced lymphopenia. Radiation-induced tumor damage promotes radio-vaccination, enhances cytotoxic immune responses, and potentiates immunotherapy. Nevertheless, radiotherapy induces systemic and intratumoral lymphopenia. The above effects are directly related to radiotherapy fractionation and field size/location, and tumor characteristics. Hypofractionated stereotactic and accelerated irradiation better promotes radio-vaccination and produces less severe lymphopenia. Adopting cytoprotective policies and combining lympho-stimulatory agents or agents blocking regulatory lymphocyte activity are awaited to unmask the radio-vaccination effect, enhancing the efficacy immuno-radiotherapy. Radiation-induced lymphopenia and immunosuppression are important issues that should be considered in the design of immuno-radiotherapy clinical trials. Copyright © 2021 Elsevier B.V. All rights reserved.

Citation

Michael I Koukourakis, Alexandra Giatromanolaki. Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy. Critical reviews in oncology/hematology. 2021 Mar;159:103226

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 33482348

View Full Text